Roche to buy US cancer drugmaker Ignyta for $1.7 bln
Swiss drugmaker Roche said on Friday it would buy U.S. cancer drugmaker Ignyta for $1.7 billion.
Friday, December 22, 2017
Roche to buy US cancer drugmaker Ignyta for $1.7 bln
Roche to buy US cancer drugmaker Ignyta for $1.7 bln
Swiss drugmaker Roche said on Friday it would buy U.S. cancer drugmaker Ignyta for $1.7 billion.
Related Posts:
0 comments:
Post a Comment